Infinimmune
Develops human-derived antibody therapeutics for atopic dermatitis and inflammatory disease
$75MSeries A
Role not disclosedGC
Goldcrest Capital
Activity from announced rounds
All recorded activity
- Rounds participated in
- 3
- Confirmed lead rounds
- — 3 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $347M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in all activityPeregrine Technologies
Builds AI platform for operational clarity in government and public safety
$250MSeries D
Role not disclosedNorthslope
Develops mission-specific AI applications on the Palantir operating system
$22MSeries A
Role not disclosed